The UK uses AI to make medicines safer and reduce animal testing
The UK uses AI to make medicines safer and reduce animal testing
Updated at: June 10, 2026 at 08:30 AM
The UK is transforming its approach to medical research by integrating artificial intelligence to modernize drug development.
As part of a national strategy to prioritize ethical, human-relevant science, the UK is actively working to replace traditional animal testing with advanced technologies.
By replacing animal trials with AI-driven analysis, organ-on-a-chip systems, and 3D bioprinted tissues, the government aims to reduce the high economic and personal costs of adverse drug reactions.
Supported by a £75 million investment, the UK has set ambitious milestones, including banning certain animal tests for skin and eye irritation by 2026 and targeting a reduction in dog and primate studies by 2030.
This shift is not just about animal welfare; it is a strategic move to accelerate the delivery of safe, innovative treatments while positioning the UK as a global leader in modern, data-driven healthcare.
